logo
Beyond BRCA1/2 : polygenic, ‘polyfunctional’ molecular circuitry model to predict breast cancer risk
Pteridine detection in urine: the future of cancer diagnostics?
Metabolic fingerprinting of bowel cancer may provide accurate and important results
Is a blood-based biomarker the future for Alzheimer's disease diagnosis?
New technique for capturing circulating tumor cells developed
Pattern in lung tumor pathology may predict recurrence
Potential biomarkers of suicide risk identified
Liver dysfunction score predicts prognosis in advanced chronic heart failure
Myocardial injury after noncardiac surgery is common and is associated with mortality
Association between low N-terminal pro-BNP and the risk of diabetes
Copeptin predicts infarct size and remodeling after ST-segment elevation myocardial infarction
Analysis of the 2010–2012 results of the multicenter external proficiency study for 25-hydroxyvitamin D
Salivary biomarker analysis complementing regular clinical examination
Associations between total serum GGT activity and metabolic risk: MESA
A-FABP and its association with atherogenic risk profile and insulin resistance in young overweight and obese women
Association of adipokines with obesity in children and adolescents
Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease
Cathepsin D as an indicator of clinical outcome in early breast carcinoma during the first 3 years of follow-up
Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber
Exosomes: the future of biomarkers in medicine
Urinary biomarkers of bladder cancer: an update and future perspectives
Biomarkers in childhood non-Hodgkin's lymphomas
Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed
Acknowledgements